SensiVida Medical Technologies Inc. (SVMT) Financi
Post# of 250675
Posted On: 11/17/2014 1:41:21 AM
SensiVida Medical Technologies Inc. (SVMT) Financials Nov 12, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for SensiVida Medical Technologies Inc.
Fiscal year is March-February. All values USD millions. 2007 2008 2009 2010 2011 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 532,153 547,622 178,987 187,237 201,926
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 532,153 547,622 178,987 187,237 201,926
Depreciation 945 817 345 - 14,690
Amortization of Intangibles 531,208 546,805 178,642 - 187,236
Gross Income (532,153) (547,622) (178,987) (187,237) (201,926)
2007 2008 2009 2010 2011 5-year trend
SG&A Expense 884,086 1.54M 1.1M 1.19M 1.76M
Research & Development 260,137 853,774 199,880 278,536 670,932
Other SG&A 623,949 684,192 899,429 906,804 1.09M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 (43,597) 0
EBIT after Unusual Expense 0 0 0 43,597 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 3,691 9,172 4,380 86 48
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 647 936,261 912,185 235,435 263,200
Gross Interest Expense 647 936,261 912,185 235,435 263,200
Interest Capitalized 0 0 0 0 0
Pretax Income (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 -
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic 0 0 0 0 -
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
EPS (Basic) (0.23) (0.46) (0.32) (0.11) (0.14)
Basic Shares Outstanding 6.23M 6.58M 6.85M 13.98M 16M
EPS (Diluted) (0.23) (0.46) (0.32) (0.11) (0.14)
Diluted Shares Outstanding 6.23M 6.58M 6.85M 13.98M 16M
EBITDA (884,086) (1.54M) (1.1M) (1.19M) (1.76M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for SensiVida Medical Technologies Inc.
Fiscal year is March-February. All values USD millions. 2007 2008 2009 2010 2011 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 532,153 547,622 178,987 187,237 201,926
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 532,153 547,622 178,987 187,237 201,926
Depreciation 945 817 345 - 14,690
Amortization of Intangibles 531,208 546,805 178,642 - 187,236
Gross Income (532,153) (547,622) (178,987) (187,237) (201,926)
2007 2008 2009 2010 2011 5-year trend
SG&A Expense 884,086 1.54M 1.1M 1.19M 1.76M
Research & Development 260,137 853,774 199,880 278,536 670,932
Other SG&A 623,949 684,192 899,429 906,804 1.09M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 (43,597) 0
EBIT after Unusual Expense 0 0 0 43,597 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 3,691 9,172 4,380 86 48
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 647 936,261 912,185 235,435 263,200
Gross Interest Expense 647 936,261 912,185 235,435 263,200
Interest Capitalized 0 0 0 0 0
Pretax Income (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 -
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic 0 0 0 0 -
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Minority Interest Expense 0 0 0 0 0
Net Income (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.41M) (3.01M) (2.19M) (1.56M) (2.23M)
EPS (Basic) (0.23) (0.46) (0.32) (0.11) (0.14)
Basic Shares Outstanding 6.23M 6.58M 6.85M 13.98M 16M
EPS (Diluted) (0.23) (0.46) (0.32) (0.11) (0.14)
Diluted Shares Outstanding 6.23M 6.58M 6.85M 13.98M 16M
EBITDA (884,086) (1.54M) (1.1M) (1.19M) (1.76M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)